Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Grem

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Cancer Research|December 1, 1986
Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levelsJ L Grem, P H Fischer
Current Opinion in Oncology|December 1, 1992
AntimetabolitesA P Chen, J L Grem
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Thymidylate synthase inhibitorsA S Ismail, J L Grem
Journal of the National Cancer Institute|September 20, 1989
Toxicity of levamisole and 5-fluorouracil in human colon carcinoma cellsJ L Grem, C J Allegra
Cancer Research|July 1, 1985
Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamoleJ L Grem, P H Fischer
Cancer Research|November 15, 1990
Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosineJ L Grem, C J Allegra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminomaJ L Grem, D L Trump
Biochemical Pharmacology|August 15, 1986
Modulation of fluorouracil metabolism and cytotoxicity by nitrothiobenzylinosineJ L Grem, P H Fischer
Biochemical Pharmacology|July 5, 1991
Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosineJ L Grem, C J Allegra
Pharmacology & Therapeutics|January 1, 1989
Enhancement of 5-fluorouracil's anticancer activity by dipyridamoleJ L Grem, P H Fischer
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Cancer Research|December 1, 1986
Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levelsJ L Grem, P H Fischer
Current Opinion in Oncology|December 1, 1992
AntimetabolitesA P Chen, J L Grem
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Thymidylate synthase inhibitorsA S Ismail, J L Grem
Journal of the National Cancer Institute|September 20, 1989
Toxicity of levamisole and 5-fluorouracil in human colon carcinoma cellsJ L Grem, C J Allegra
Cancer Research|July 1, 1985
Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamoleJ L Grem, P H Fischer
Cancer Research|November 15, 1990
Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosineJ L Grem, C J Allegra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminomaJ L Grem, D L Trump
Biochemical Pharmacology|August 15, 1986
Modulation of fluorouracil metabolism and cytotoxicity by nitrothiobenzylinosineJ L Grem, P H Fischer
Biochemical Pharmacology|July 5, 1991
Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosineJ L Grem, C J Allegra
Pharmacology & Therapeutics|January 1, 1989
Enhancement of 5-fluorouracil's anticancer activity by dipyridamoleJ L Grem, P H Fischer
Pageof 12